Medtronic v. Tyco
This article was originally published in The Gray Sheet
Executive Summary
Preliminary injunction prohibiting Surgical Dynamics (a division of Tyco's U.S. Surgical business) from producing, using, selling or offering to sell its Ray TFC spinal fusion cage becomes effective Aug. 30 (1"The Gray Sheet" Aug. 23, In Brief)
You may also be interested in...
Medtronic v. Tyco
California federal district court grants preliminary injunction against spinal fusion cage rival Surgical Dynamics (a division of Tyco's U.S. Surgical business) prohibiting it from selling its Ray TFC spinal implant fusion cage. Medtronic alleges that the device infringes patents for its Inter Fix threaded spinal fusion device. The injunction, which was announced Aug. 16 and reinforces an April 16 federal appeals court reversal in Medtronic's favor (1"The Gray Sheet" May 3, p. 19), is temporary pending completion of patent validity trial proceedings
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.